Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
LIVOSTIN Gtt Opht 0.5 mg/ml Fl 4 ml
Drug
Livostin Augentropfen, Augentropfensuspension
Allergische Konjunktivitis
11.06.2. – antiallergics
HAM – Human medicine
AUGN – Eye drops, suspension
S – synthetic products for human use
D – Dispensed following expert advice (D)
Z – approved
2/28/1992
12/31/9999
Dosage strength
Livostin Augentropfen, Augentropfensuspension
Allergische Konjunktivitis
01
Z – approved
Package
7680504960234
No information made available
A/R – Authorised / referenced
4 ml
023
Z – approved
Declaration
Component
0.5 mg levocabastinum
levocabastini hydrochloridum
levocabastini hydrochloridum
propylenglycolum
dinatrii phosphas
natrii dihydrogenophosphas monohydricus
9.5 mg phosphas
0.15 mg benzalkonii chloridum
hypromellosum
polysorbatum 80
dinatrii edetas
aqua ad iniectabile
dinatrii phosphas
natrii dihydrogenophosphas monohydricus
9.5 mg phosphas
0.15 mg benzalkonii chloridum
hypromellosum
polysorbatum 80
dinatrii edetas
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
13.35
None
No
10%
No
Authorisation holder
7609999408403
JNTL Consumer Health II
Gubelstrasse 34
6300 Zug (ZG)
Gubelstrasse 34
6300 Zug (ZG)
Date of revision of the text
3/19/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.